iZafe Group AB Series B Asset Resilience Ratio
iZafe Group AB Series B asset resilience ratio. iZafe Group AB Series B (IZAFE-B) has an Asset Resilience Ratio of 4.69% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See iZafe Group AB Series B liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of iZafe Group AB Series B (2016–2025)
Asset resilience ratio of iZafe Group AB Series B from 2016 to 2025. This chart shows how iZafe Group AB Series B's Asset Resilience Ratio has changed over time. Read how much debt does iZafe Group AB Series B carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down iZafe Group AB Series B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see iZafe Group AB Series B balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr1.67 Million | 4.69% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr1.67 Million | 4.69% |
Asset Resilience Insights
- Limited Liquidity: iZafe Group AB Series B maintains only 4.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
iZafe Group AB Series B Industry Peers by Asset Resilience Ratio
Compare iZafe Group AB Series B's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.55% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
iZafe Group AB Series B Asset Resilience Ratio by Year (2016–2025)
iZafe Group AB Series B asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for iZafe Group AB Series B.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.69% | Skr1.67 Million ≈ $180.04K |
Skr35.63 Million ≈ $3.83 Million |
-4.18pp |
| 2024-12-31 | 8.87% | Skr2.15 Million ≈ $231.37K |
Skr24.23 Million ≈ $2.61 Million |
-7.98pp |
| 2023-12-31 | 16.85% | Skr5.83 Million ≈ $627.83K |
Skr34.61 Million ≈ $3.73 Million |
+13.50pp |
| 2022-12-31 | 3.35% | Skr1.70 Million ≈ $183.05K |
Skr50.70 Million ≈ $5.46 Million |
-35.31pp |
| 2021-12-31 | 38.67% | Skr18.73 Million ≈ $2.02 Million |
Skr48.43 Million ≈ $5.21 Million |
+31.40pp |
| 2020-12-31 | 7.26% | Skr2.55 Million ≈ $274.21K |
Skr35.08 Million ≈ $3.78 Million |
-3.14pp |
| 2019-12-31 | 10.41% | Skr7.47 Million ≈ $803.57K |
Skr71.75 Million ≈ $7.72 Million |
+7.64pp |
| 2018-12-31 | 2.77% | Skr1.21 Million ≈ $129.89K |
Skr43.58 Million ≈ $4.69 Million |
-23.36pp |
| 2017-12-31 | 26.13% | Skr3.58 Million ≈ $385.70K |
Skr13.71 Million ≈ $1.48 Million |
-17.89pp |
| 2016-12-31 | 44.03% | Skr3.56 Million ≈ $383.44K |
Skr8.09 Million ≈ $870.88K |
-- |
About iZafe Group AB Series B
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also o… Read more